Ramis Laboratories Private Limited

Ramis Laboratories Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24232TG2007PTC055590 Incorporated 19 September 2007 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹21.59 Cr
▲ 192% YoY
Net profit · FY 2024
₹47.06 Lakh
Net margin 2.2%
EBITDA · FY 2024
₹4.25 Cr
EBITDA margin 19.7%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹2.51 Cr
Issued & subscribed
Open charges
₹22.38 Cr
Satisfied ₹14.77 Cr
Company age
19 yrs
Est. 2007
Directors on board
2
As per MCA filings

About Ramis Laboratories Private Limited

Data last updated:

Ramis Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 19 September 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2007PTC055590. Its GSTIN is 36AADCB8504A1Z6 (Telangana). The company holds 4 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.51 Cr. It was formerly known as Bondbay Pharmaceuticals Private Limited. It is led by directors Sridhara Reddy Gandra and Venkata Rami Reddy Goli.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2024, the company reported a revenue of ₹21.59 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹47.06 Lakh (net margin 2.2%) and EBITDA of ₹4.25 Cr (EBITDA margin 19.7%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years and 76% over five years.

The company is associated with 1 brand: Bondbay Pharmaceuticals. As per MCA filings, the company has open charges of ₹22.38 Cr and satisfied charges of ₹14.77 Cr on record. Court records list 19 cases involving the company, including 1 filed by the company and 18 filed against it; 18 cases are pending. The company has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹25.5 Lakh; the latest was in January 2022. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Yegna Manojavam Drugs & Chemicals Limited with revenue of ₹23.07 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ramislabs.com.

Company Details of Ramis Laboratories Private Limited
CIN U24232TG2007PTC055590
Registration Number 055590
Incorporation Date 19 September 2007
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Plot No.113&114 2nd Floor Alep Industrial Estate Near Pragathi Nagar Gajularamaram(Villag, E), Hyderabad, Telangana, India – 500055
  • Industry
    Pharma, API Manufacturers, Drug Formulation & Development
Comprehensive company report
Ramis Laboratories Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Ramis Laboratories Private Limited report

Financials, compliance, directors, charges, ownership and filings for Ramis Laboratories Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Ramis Laboratories Private Limited

The main business activity of Ramis Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Ramis Laboratories Private Limited FY 2024 filings available

Ramis Laboratories Private Limited reported revenue of ₹21.59 Cr (up 192% YoY) for FY 2024.

Revenue · FY 2024
₹21.59 Cr ▲ 192%
Net profit · FY 2024
₹47.06 Lakh margin 2.2%
EBITDA · FY 2024
₹4.25 Cr margin 19.7%

Compounded Annual Growth Rate (CAGR) of Ramis Laboratories Private Limited

Revenue CAGR growth
1 year
▲ 192%
3 years · compounded
▲ 52%
5 years · compounded
▲ 76%
EBITDA CAGR growth
1 year
▲ 138%
3 years · compounded
▲ 139%
5 years · compounded
▲ 96%

Revenue has grown at a compounded annual rate (CAGR) of 76% over five years, including 192% growth in the latest year. EBITDA rose 138% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Ramis Laboratories Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹4.25 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹47.06 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Ramis Laboratories Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin19.7%••••••••••••••••
Net Profit Margin2.2%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ramis Laboratories are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Ramis Laboratories Private Limited

Ramis Laboratories Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Yegna Manojavam Drugs & Chemicals Limited₹23.07 Cr (FY 2018)••••••••32.0%••••Hyderabad, Telangana, India
Kekule Life Sciences Limited₹22.9 Cr (FY 2024)••••••••33.0%••••Hyderabad, Telangana, India
Innorex Pharmaceuticals Private Limited₹22.73 Cr (FY 2025)••••••••90.0%••••Mumbai, Maharashtra, India
Shakti Lifescience Private Limited₹21.77 Cr (FY 2025)••••••••-4.0%••••Mumbai, Maharashtra, India
Ransh Pharma Private Limited₹21.75 Cr (FY 2025)••••••••27.0%••••Visakhapatnam, Andhra Pradesh, India
Ramis Laboratories Private Limited this company₹21.59 Cr (FY 2024)••••••••192.0%••••Hyderabad, Telangana, India
Alchymars Icm SM Private Limited₹21.14 Cr (FY 2021)••••••••44.0%••••Alathur, Tamil Nadu, India
Avance Healthcare Private Limited₹21.12 Cr (FY 2025)••••••••19.0%••••Rajkot, Gujarat, India
Vav Life Sciences Private Limited₹20.87 Cr (FY 2025)••••••••-3.0%••••Mumbai, Maharashtra, India
Norrish Laboratories Private Limited₹20.76 Cr (FY 2024)••••••••168.0%••••Hyderabad, Telangana, India
Anphar Laboratories Private Limited₹20.75 Cr (FY 2025)••••••••27.0%••••Jammu, Jammu and Kashmir, India

Peers are the five companies nearest above and the five nearest below Ramis Laboratories by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Ramis Laboratories Private Limited

Ramis Laboratories Private Limited is audited by MSPR & CO for the financial year 2022.

NameStatusAppointment DateCessation Date
MSPR & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Ramis Laboratories Private Limited

Ramis Laboratories has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sridhara Reddy GandraDirector20 Apr 201016 Years 5 MonthsCurrent
Venkata Rami Reddy GoliDirector19 Sep 200719 Years 0 MonthsCurrent

Ownership and Shareholding of Ramis Laboratories Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Ramis Laboratories Private Limited

Open charges
₹22.38 Cr
Satisfied charges
₹14.77 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹20.43 Cr
Karnataka Bank Ltd.₹1.38 Cr
Axis Bank Limited₹0.57 Cr
Latest charge details
DateLenderAmountStatus
28 Dec 2023Hdfc Bank Limited₹20.43 CrOpen
19 Oct 2023Axis Bank Limited₹57 LakhOpen
28 Feb 2022Karnataka Bank Ltd.₹1 CrOpen
23 Nov 2021Karnataka Bank Ltd.₹38 LakhOpen
15 Apr 2023Karnataka Bank Ltd.₹4 CrSatisfied

Total charge records: 9 View all charges

Deals & Funding of Ramis Laboratories Private Limited

Ramis Laboratories Private Limited has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹25.5 Lakh; the latest was in January 2022.

Total deals
6
Secondary share transfers
4
Rights issue
1
Funding round
1
Disclosed funding
₹25.5 Lakh

Deals on record (5 of 6)

WhenDealAmountParties
Jan 2022Rights issue₹2.2 CrInvestors: 3 individuals
Dec 2017Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
May 2015Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Apr 2015Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
Mar 2014Funding round₹25.5 LakhInvestors: 4 individuals
Premium access

Full deal history

All 6 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Associated Brands with Ramis Laboratories Private Limited

Ramis Laboratories operates one associated brand: Bondbay Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures pharmaceutical raw materials, drug intermediates, and APIs for industry supply.bondbaypharma.com

Employees and EPFO Compliance at Ramis Laboratories Private Limited

Employment history and EPFO contributions of people linked to Ramis Laboratories.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

CIN History of Ramis Laboratories Private Limited

Ramis Laboratories has one previous CIN (Corporate Identification Number): U24232AP2007PTC055590. The current CIN is U24232TG2007PTC055590, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232TG2007PTC055590Current
U24232AP2007PTC055590Previous

Recent Activity on Ramis Laboratories Private Limited

Ramis Laboratories Private Limited has 5 board changes on record since 2007: 2 appointments and 3 cessations. The latest: Sreedhar Tirumala ceased to be Director on 12 Aug 2017.

AGM
Ramis Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Ramis Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited of Rs. 20.43 Cr registered on 28 Dec 2023 with Charge ID 100841389 was modified on 20 Jan 2024.
Charges
A charge registered on 15 Apr 2023 via Charge ID 100726530 with Karnataka Bank Ltd. was fully satisfied on 11 Jan 2024.
Charges
A charge registered on 30 Apr 2022 via Charge ID 100565221 with Karnataka Bank Ltd. was fully satisfied on 11 Jan 2024.
Charges
A charge registered on 28 Feb 2022 via Charge ID 100545889 with Karnataka Bank Ltd. was fully satisfied on 11 Jan 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 20.43 Cr with Charge ID 100841389 was registered on 28 Dec 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.57 Cr with Charge ID 100813454 was registered on 19 Oct 2023.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 4.00 Cr with Charge ID 100726530 was registered on 15 Apr 2023.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 0.13 Cr with Charge ID 100565221 was registered on 30 Apr 2022.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 1.00 Cr with Charge ID 100545899 was registered on 28 Feb 2022.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 9.00 Cr with Charge ID 100545889 was registered on 28 Feb 2022.

12 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Ramis Laboratories Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Ramis Laboratories Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Ramis Laboratories Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Ramis Laboratories Private Limited

Ramis Laboratories has 4 GST registrations: 2 active and 2 cancelled or inactive.

Total GSTINs
4
Active
2
Cancelled / inactive
2
GSTINStateStatusRegistered on
36AADCB8504A1Z6TelanganaActive01 Jul 2017
29AADCB8504A2Z0KarnatakaActive02 Feb 2021
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Ramis Laboratories Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramis Laboratories Private Limited

Ramis Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 19 September 2007 (19+ years old) and is registered under CIN U24232TG2007PTC055590.

Ramis Laboratories reported revenue of ₹21.59 Cr for FY 2024 (up 192% YoY).

Ramis Laboratories has 2 current directors:

Ramis Laboratories reported a net profit of ₹47.06 Lakh (net margin 2.2%) and EBITDA of ₹4.25 Cr (EBITDA margin 19.7%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Ramis Laboratories is 52% over three years and 76% over five years. In the latest year (FY 2024) revenue rose 192%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Ramis Laboratories is 36AADCB8504A1Z6, registered in Telangana. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 29AADCB8504A2Z0 (Karnataka).

The CIN (Corporate Identification Number) of Ramis Laboratories is U24232TG2007PTC055590. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ramis Laboratories has 19 court cases on record: 1 filed by the company and 18 filed against it. 18 are pending.

Ramis Laboratories was incorporated on 19 September 2007, making it 19+ years old. It is registered with the Registrar of Companies, Hyderabad.

Ramis Laboratories has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹25.5 Lakh; the latest was in January 2022.

The peers of Ramis Laboratories by revenue are Yegna Manojavam Drugs & Chemicals Limited, Kekule Life Sciences Limited, Innorex Pharmaceuticals Private Limited, Shakti Lifescience Private Limited, Ransh Pharma Private Limited and 5 more, all in the Pharma industry (API Manufacturers).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available